TP53 and cancer: Preneoplastic and cancer cells adapted to living with unphysiological levels of genomic instability, oxidative stress, and P53 loss impeding cell-cycle arrest, apoptosis, or senescence induction in these conditions, all potent antitumor mechanisms.